This subtype is mostly found in progressive primary bone tumors as well as in metastatic sites, resulting in increased angiogenesis via the secretion of VEGF and matrix metallopeptidase (MMP9), which help to promote tumor growth and proliferation [38,39]. The gene discussed is MMP9; the disease is bone neoplasm.